SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,419 | +70.2% | 3,295 | +60.8% | 0.03% | +80.0% |
| Q2 2023 | $234,651 | -48.8% | 2,049 | -38.4% | 0.02% | -51.6% |
| Q1 2023 | $458,698 | +6.4% | 3,328 | 0.0% | 0.03% | -6.1% |
| Q4 2022 | $431,242 | +42.8% | 3,328 | +21.7% | 0.03% | +32.0% |
| Q3 2022 | $302,000 | -50.9% | 2,734 | -24.3% | 0.02% | -67.1% |
| Q4 2020 | $615,000 | +0.5% | 3,611 | -17.2% | 0.08% | -12.6% |
| Q3 2020 | $612,000 | +7.4% | 4,360 | +22.5% | 0.09% | -2.2% |
| Q2 2020 | $570,000 | +63.8% | 3,560 | 0.0% | 0.09% | +29.0% |
| Q1 2020 | $348,000 | -17.7% | 3,560 | +8.5% | 0.07% | +1.5% |
| Q4 2019 | $423,000 | +71.3% | 3,280 | 0.0% | 0.07% | +58.1% |
| Q3 2019 | $247,000 | -41.7% | 3,280 | +17.6% | 0.04% | -43.4% |
| Q2 2019 | $424,000 | +27.7% | 2,790 | 0.0% | 0.08% | +8.6% |
| Q1 2019 | $332,000 | +89.7% | 2,790 | +73.3% | 0.07% | +66.7% |
| Q4 2018 | $175,000 | +80.4% | 1,610 | +168.3% | 0.04% | +100.0% |
| Q3 2018 | $97,000 | – | 600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |